Controlled substances (CS) used in health care systems and narcotic treatment programs pose a serious risk for drug diversion. CS diversion causes harm to the diverter and raises serious liability issues to the organization which can face significant fines for noncompliance to DEA drug disposal regulations. Drug diversion leads to inaccurate documentation, puts patients at risk for inadequate pain relief and increases the risk of exposure to infectious disease in the healthcare environment.
The Drug Enforcement Administration (DEA) proposes to revise existing regulations, 21 CFR Parts 1300, 1301, and 1304, pertaining to Registration Requirements for Narcotic Treatment Programs with Mobile Components. Narcotic treatment programs, NTPs, often operate with mobile components to dispense narcotic prescriptions from a remote location for use in a detoxification or maintenance program. Under this proposed rule, these mobile NTPs would waive the requirement to obtain a separate registration for each principal location where controlled substances are dispensed.
The purpose for this proposal is to make detoxification or maintenance treatment programs more widely accessible while also ensuring that safeguards are in place to reduce the chances of drug diversion.
Controlled Substance Diversion Prevention Program
A controlled substance diversion prevention program must contain core elements including:
- Core administrative elements
- Organization accountability and oversight
- Regulatory and legal requirements
- System-level controls
- Technology and automation
- Surveillance and monitoring
- Human resources management
- Reporting and investigation
- Provider level controls
- Storage and security
- Chain of custody
- Internal pharmacy controls
- Administration and prescribing
- Prescription returns, waste and proper disposal
C2R Global Manufacturing, Inc. Offers Compliant CS Waste Disposal Solutions
C2R Global Manufacturing, Inc. offers pharmaceutical waste disposal solutions including controlled substance waste from narcotic treatment programs. We offer simple and affordable products which meet all DEA and the EPA compliance regulations as part of your medication waste disposal system. Our patented* formula neutralizes prescriptions on contact, providing a safeguard against drug diversion and eliminating environmental contamination.
We offer a wide selection of drug disposal products in convenient sizes to meet the needs of various industries and environments. You can find our products in many healthcare facilities, hospitals, correctional facilities and more. We offer in-depth industry expertise, training and full DEA compliance consultation and services.
C2R Global Manufacturing, Inc. offers simple to use prescription disposal containers in sizes ranging from 4 ounces to 30 gallon drums. We support healthcare facilities and narcotic treatment programs with safe and compliant drug disposal solutions. Contact us to learn more about maintaining compliance with CS waste disposal in narcotic treatment programs.